The growth of this market is driven by the increasing prevalence of cardiovascular diseases; launch of innovative products by market players; availability of reimbursement for CM & CRM devices; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices.
According to research report Cardiac Monitoring Market is projected to reach $26.8 billion by 2025, at a CAGR of 4.0% from 2020 to 2025.
By end user, the cardiac rhythm management devices market is segmented into hospitals; cardiac centers; clinics and ambulatory surgery centers (ASCs); and other end users. Hospitals accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the increasing prevalence of CVD, increasing number of cardiac implant procedures, the growing number of patient visits to hospitals for diagnosis and the availability of reimbursement for these procedures across developed markets
The major players operating in this Cardiac Monitoring Market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55